Pediatrics
Showing 1-50 of 81 Results
-
Xavier Gaeta MD PhD
Instructor, Pediatrics - Nephrology
BioDr. Xavier Gaeta is an Instructor in the division of Pediatric Nephrology and a postdoctoral fellow in the lab of Dr. Calvin J. Kuo. His research interests include using three-dimensional human kidney organoids and genetic engineering techniques to model human kidney disease, kidney development, and cancer in vitro.
-
Francisco Galdos
Affiliate, Department Funds
Fellow in Pediatrics - CardiologyBioFrancisco earned his undergraduate degree in Human Developmental and Regenerative Biology from Harvard University, graduating magna cum laude. He subsequently completed his MD/PhD at Stanford University School of Medicine. During his doctoral training under the mentorship of Dr. Sean Wu, Francisco published one of the first comprehensive maps of human cardiac cell development using pluripotent stem cell-based models. His research contributed to the development of machine learning tools and genetic tracing systems that identified and characterized human left ventricular cardiomyocytes in vitro, enabling the modeling of left ventricular development in hypoplastic left heart syndrome. Francisco has authored multiple first-author publications and has been awarded funding from both internal sources and the NIH (F30, T32). He has received numerous accolades for his work, including the prestigious Harold Weintraub Award, and has presented his research at various national conferences. As part of the accelerated research pathway at Stanford, Francisco is focused on the genetic and epigenetic mechanisms underlying heart failure and heart development in congenital heart disease, with the ultimate goal of developing novel therapeutics for pediatric patients.
-
Rodrigo B. Galindo
CAPE Simulation Lab Manager and Operations Specialist, Pediatrics - Neonatology
Current Role at StanfordRodrigo Galindo manages technology and supports research and education for simulation programs at the Center for Advanced Pediatric & Perinatal Education (CAPE) (http://cape.stanford.edu) within the School of Medicine/Pediatrics/Neonatology division. He also assists with collaborative quality improvement initiatives between CAPE and the departments of Labor & Delivery, Neonatal Intensive Care Unit (NICU), and Obstetrics at Lucile Packard Children’s Hospital.
-
Hayley Gans
Current Research and Scholarly InterestsThe focus of my laboratory is the immune response to viral vaccines evaluating the ontogeny of responses in infants and limitations in immunocompromised hosts. We have studied responses to an early two-dose measles immunization, one versus 2 doses of varicella immunization, and polio vaccine in preterm versus term infants. Other active areas of research include measles and varicella immunity in HIV infected individuals, and transplant recipients.
-
Chris Garcia
Younger Family Professor and Professor of Structural Biology
Current Research and Scholarly InterestsStructural and functional studies of transmembrane receptor interactions with their ligands in systems relevant to human health and disease - primarily in immunity, infection, and neurobiology. We study these problems using protein engineering, structural, biochemical, and combinatorial biology approaches.
-
Manuel Garcia-Careaga
Current Research and Scholarly InterestsGastroenterology, liver disease in cystic fibrosis patients, percutaneous gastrostomy tube in pediatric population, inflamatory bowel disease, failure to thrive
-
Christopher Gardner
Rehnborg Farquhar Professor
Current Research and Scholarly InterestsThe role of nutrition in individual and societal health, with particular interests in: plant-based diets, differential response to low-carb vs. low-fat weight loss diets by insulin resistance status, chronic disease prevention, randomized controlled trials, human nutrition, community based studies, Community Based Participatory Research, sustainable food movement (animal rights and welfare, global warming, human labor practices), stealth health, nutrition policy, nutrition guidelines
-
Brice Gaudilliere
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD) and, by courtesy, of Pediatrics (Neonatology)
Current Research and Scholarly InterestsThe advent of high dimensional flow cytometry has revolutionized our ability to study and visualize the human immune system. Our group combines high parameter mass cytometry (a.k.a Cytometry by Time of Flight Mass Spectrometry, CyTOF), with advanced bio-computational methods to study how the human immune system responds and adapts to acute physiological perturbations. The laboratory currently focuses on two clinical scenarios: surgical trauma and pregnancy.
-
Charles Gawad
Associate Professor of Pediatrics (Hematology/Oncology)
BioOur lab works at the interface of biotechnology, computational biology, cellular biology, and clinical medicine to develop and apply new tools for characterizing genetic variation across single cells within a tissue with unparalleled sensitivity and accuracy. We are focused on applying these technologies to study cancer clonal evolution while patients are undergoing treatment with the aim of identifying cancer clonotypes that are associated with resistance to specific drugs so as to better understand and predict treatment response. We are also applying these methods to understand how more virulent pathogens emerge from a population of bacteria or viruses with an emphasis on developing a deeper understanding of how antibiotic resistance develops.
-
Benedikt Geier
Postdoctoral Scholar, Infectious Diseases
BioB.Sc. Biology, Ludwig Maximilian University (LMU), Munich/Germany (2013)
M.Sc. Biology and bioimaging, Ludwig Maximilian University (LMU), Munich/Germany (2015)
Ph.D., Animal-Microbe Symbioses, Max Planck Institute for Marine Microbiology in Bremen/Germany (2020)
Benedikt joined the Amieva Lab from Germany in 2022. During his B.Sc. and M.Sc. programs in zoology, he became fascinated with 3D imaging approaches to study small animal microanatomy. He spent his PhD developing in situ imaging approaches to study deep-sea symbioses and fell in love with studying host-microbe interactions. In the Amieva Lab, Benedikt will advance his previously developed correlative chemical imaging techniques to resolve metabolic and cellular interactions that drive H. pylori pathogenesis in the gastric glands.
More about Benedikt's transition from deep-sea microbiology into infectious disease research can be found here:
https://scopeblog.stanford.edu/2022/08/24/unconventional-paths-deep-sea-to-the-stomach/ -
Yael Gernez
Clinical Associate Professor, Pediatrics - Immunology
BioMy clinic focuses on solving the molecular puzzles that underlie rare allergic and immunologic diseases to shed light on fundamental principles governing allergy, inflammation and immune system defects. My goal is to find better and safer therapies for my patients with rare diseases that include autoinflammation, autoimmunity and primary immune deficiency. It is important to highlight that every patient requires individualized therapeutic approaches based on their underlying genetic problem and the types and severity of their clinical manifestations. For some patients, a hematopoietic stem cell transplant (HSCT) is curative while for others, a targeted drug therapy, such as a biologic or small molecule agent, is most suitable. In some cases, a truly novel therapy may be required, .e.g., anti-sense oligonucleotide therapy to suppress aberrant gene splicing or adoptive cellular therapy. My passion is to provide the best personalized therapy for our patients with allergy and immunology diseases. This often requires performing very specialized functional assays and in some cases in enlisting laboratories with specific expertise or interest in particular genetic disorders.
-
Zahra Ghazi-Askar
Clinical Associate Professor, Emergency Medicine
Clinical Associate Professor, PediatricsBioDr. Ghazi-Askar is Assistant Professor of Emergency Medicine and, by courtesy, of Pediatrics and serves as the Director of Pediatric Ultrasound Education in the Department of Emergency Medicine . As an academic clinical educator in with expertise in pediatric and adult point-of-care ultrasound, Dr. Ghazi-Askar's clinical focus is on children and young adults who seek care in the pediatric emergency department. She is specialty-board certified in pediatric emergency medicine.
At a national level, Dr. Ghazi-Askar is the Chair of Point-of-Care Ultrasound subcommittee for the Association of Pediatric Program Directors (APPD), where she is leading the development of an educational curriculum for pediatric residency point-of-care ultrasound.
Dr. Ghazi-Askar also has expertise in the field of Tele-ultrasound, where she is able to teach point-of-care ultrasound virtually where clinical expertise may otherwise not be available. Here she is able to provide education and health equity when it is most needed. -
Ruth Margaret Gibson
Visiting Scholar, Medicine - Primary Care and Population Health
Affiliate, Pediatrics - NeonatologyBioDr. Ruth Gibson, PhD, is a scholar at Stanford University. She holds appointments at the Center for Innovation and Global Health (CIGH) and the Center for International Security and Cooperation (CISAC). Dr. Gibson’s research focuses on war, blockades, and sanctions and their impacts on maternal and child health. Her expertise is in geopolitically complex regions of the world, crises, and what all of this means for human health.
Dr. Gibson’s research is published in internationally renowned outlets such as The Lancet and The Lancet Global Health. She publishes research on issues such as foreign aid withdrawal and impacts on mothers and children, humanitarian catastrophe in Gaza, and sanctions against Iran. Her insights have been highlighted by The New York Times, The New Yorker, and TIME. Dr. Gibson responds quickly to producers, journalists, and media outlets seeking expert analysis of critical issues in war, peace, and human lives.
She is currently co-leading a Lancet Series on Global Health and Foreign Engagement with Professor Gary Darmstadt. She leads worldwide international panels on critical issues in global health – geopolitical crisis and their impacts on health – through the Consortium of Universities for Global Health (CUGH) and Stanford’s CIGH. Dr. Gibson collaborates with the United Nations High Commission for Human Rights to develop a universal monitoring system to assess the impact of sanctions on human rights. Her research has been cited in UN General Assembly meetings. She also worked on war crimes investigations with the Yale Humanitarian Research Lab and on the International Criminal Court's prosecution of war crimes.
Dr. Gibson spent a decade working internationally, engaging in humanitarian and global health initiatives across eight countries on five continents – including conflict zones. Dr. Gibson is fluent in English and proficient in Mandarin Chinese (如詩 吉布森), French, and Spanish. She holds a postdoctoral fellowship from Stanford University, a PhD from the University of British Columbia, an Honors Bachelor of Science, and a Master of Science from the University of Toronto.
Dr. Gibson can be reached at rmgibson@stanford.edu
https://drruthgibson.com/ -
Alex Gileles-Hillel, MD
Visiting Scholar, Pediatrics - Pulmonary Medicine
BioAlex Gileles-Hillel, MD, ATSF, is a pediatric pulmonologist and sleep medicine physician at Hadassah Medical Center and Associate Professor of Pediatrics at the Hebrew University of Jerusalem. He directs the Neonatal Pulmonology Service at Hadassah and is a Visiting Scholar at Stanford University for 2026–27. His clinical interests include pediatric sleep-disordered breathing, chronic lung disease of prematurity, asthma, cystic fibrosis, primary ciliary dyskinesia, and complex respiratory disorders in infants and children.
Dr. Gileles-Hillel completed his medical training, pediatric residency, and pediatric pulmonology fellowship at the Hebrew University–Hadassah Medical Center. He then completed advanced fellowship training in sleep medicine at the University of Chicago under David Gozal, followed by postdoctoral training in vascular biology at the Hebrew University. He is the founder and director of the Gileles Lab, where his group investigates the mechanisms and consequences of obstructive sleep apnea and intermittent hypoxia, including cardiometabolic dysfunction, vascular injury, and cancer progression. The lab also develops human-derived airway organoid models to study asthma, cystic fibrosis, and primary ciliary dyskinesia, with the goal of translating mechanistic insights into improved care for children with respiratory disease. -
Rachel Gilgoff
Adjunct Clinical Associate Professor, Pediatrics - Allergy and Clinical Immunology
BioAs a board-certified general pediatrician, child abuse pediatrician, and integrative medicine specialist, Dr. Gilgoff brings a multidisciplinary, whole-family approach to ACEs, toxic stress, healing, and well-being. She is currently an advisor with the California Aces Aware Initiative, UCLA-UCSF ACEs Aware Family Resilience Network (UCAAN), and the Center for Youth Wellness, a program of Safe and Sound, as well as an Adjunct Clinical Associate Professor at Stanford University School of Medicine. She is the co-founder of the National Committee on Asthma and Toxic Stress and co-PI on “Systems-based, Multidisciplinary Assessment of Adversity and Toxic Stress for Individualized Care (The SYSTEMAATIC Project),” an ACEs and Precision Medicine research project through the California Initiative to Advance Precision Medicine (CIAPM). She co-created the “Stress Busters: Clinical Strategies for Preventing and Mitigating Toxic Stress,” a free, on-line course to help clinicians develop their clinical response to childhood adversity and toxic stress. In tandem, she led the development of the ACEs Aware Stress Busters Resource Webpage, sharing tools and resources to prevent and heal toxic stress for all of us. Dr. Gilgoff is dedicated to conducting translational research and promoting patient-centered, individualized, multidisciplinary clinical care to address health issues resulting from child abuse and toxic stress.
Board Certification:
American Board of Physician Specialties, Integrative Medicine (2022)
American Board of Pediatrics, Child Abuse Pediatrics (2011)
American Board of Pediatrics, General Pediatrics (2004)
Professional Education
Fellowship:
Integrative Psychiatry Institute, Integrative Psychiatry (2023)
Andrew Weil Center for Integrative Medicine (2022)
Stanford University Medical Center, Pediatric Integrative Medicine (2021)
UCSF Benioff Children’s Hospital Oakland and UC Davis, Child Abuse Pediatrics (2007)
Residency:
UCSF Benioff Children’s Hospital and Research Center at Oakland (2004)
Medical Education:
Keck School of Medicine, USC (2001)
Selected Publications
Gilgoff R, Marshall J, Kotz K, Ismail S, Harsamizadeh Tehrani S,…; ACEs Aware Patient Advisors; ACEs Aware Community Partner Council. (2025) “Stress Busters Toolkit for Community Based Organizations: Strategies to help clients prevent and heal from toxic stress.” California ACEs Aware Initiative, Office of the California Surgeon General, and the California Department of Health Care Services. https://www.acesaware.org/managestress/cbotoolkit/
Gilgoff, R., Mengelkoch, S,, Elbers, J., Kotz, K., Radin, A., Pasumarthi, I., Murthy, R., Sindher, S., Burke Harris, N., Slavich, G.E. (2024) The Stress Phenotyping Framework: A Multidisciplinary Biobehavioral Approach for Assessing and Therapeutically Targeting Maladaptive Stress Physiology. Stress. 27 (1).
Gilgoff R, Schwartz T, Owen M, Bhushan D, Burke Harris N. (2023) Opportunities to Treat Toxic Stress. Pediatrics. Jan 1;151(1):e2021055591.
Jeung, J., Hessler Jones, D., Frame, L., Gilgoff, R., Long, D., Thakur, N., Koita, K., Bucci, M., Burke Harris, N. (2022) A Caregiver-Child Intervention for Mitigating Toxic Stress (“The Resiliency Clinic”): A Pilot Study. Matern Child Health J.
Bhushan D, Kotz K, McCall J, Wirtz S, Gilgoff R, Dube SR, Powers C, Olson-Morgan J, Galeste M, Patterson K, Harris L, Mills A, Bethell C, Burke Harris N. (2020) Office of the California Surgeon General. Roadmap for Resilience: The California Surgeon General’s Report on Adverse Childhood Experiences, Toxic Stress, and Health. Office of the California Surgeon General.
Gilgoff R, Singh L, Koita K, Gentile B, Marques SS. (2020) Adverse Childhood Experiences, Outcomes, and Interventions. Pediatr Clin North Am. Apr;67(2):259-273. -
Bertil Glader
Stanford Medicine Professor of Pediatric Hematology/Oncology, Emeritus
Current Research and Scholarly InterestsHematology/Oncology, biology, and treatment of bone marrow failure disorders, hereditary coagulation disorders-clinical trials.
-
Greg Glasscock
Clinical Associate Professor, Pediatrics - Neonatology
Current Research and Scholarly InterestsNeonatal Endocrinology
-
Anna L Gloyn
Professor of Pediatrics (Endocrinology) and of Genetics
Current Research and Scholarly InterestsAnna's current research projects are focused on the translation of genetic association signals for type 2 diabetes and glycaemic traits into cellular and molecular mechanisms for beta-cell dysfunction and diabetes. Her group uses a variety of complementary approaches, including human genetics, functional genomics, physiology and islet-biology to dissect out the molecular mechanisms driving disease pathogenesis.
-
Neville H. Golden M.D.
Marron and Mary Elizabeth Kendrick Professor of Pediatrics, Emeritus
Current Research and Scholarly InterestsMy research has focused on the medical complications of adolescents with eating disorders. My specific area of study has been the etiology and implications of amenorrhea in adolescents with eating disorders, in particular the management of reduced bone mass and osteoporosis in anorexia nervosa.
-
Natalia Gomez-Ospina
Assistant Professor of Pediatrics (Genetics)
Current Research and Scholarly Interests1. Genome Editing and HSPC-Based Therapeutics
Dr. Gomez-Ospina’s research focuses on developing autologous hematopoietic stem and progenitor cell therapies using CRISPR/Cas9-mediated genome editing. Her work includes targeted integration of therapeutic transgenes into genomic safe-harbor loci, optimization of editing efficiency and safety, and development of transplantation and conditioning strategies that preserve long-term engraftment. A major goal is to create reusable, mutation-agnostic therapeutic platforms that can be adapted across diseases. Her translational work also extends to GMP manufacturing, analytical development, and IND-enabling studies needed to move genome-edited HSPC products toward clinical trials.
2. Neurometabolic and Neurodegenerative Disease Therapeutics
A major area of interest is the development of definitive therapies for lysosomal storage disorders and other neurogenetic diseases, including MPS I, Gaucher disease, Krabbe disease, progranulin deficiency, and Friedreich’s ataxia. Her laboratory investigates how hematopoietic-derived cells can deliver therapeutic proteins to peripheral tissues and the central nervous system. This includes strategies to enhance microglial replacement, improve CNS engraftment, and harness myeloid cells as therapeutic vehicles. The broader objective is to establish cell-based approaches capable of treating both inherited neurometabolic disorders and more common neurodegenerative diseases.
3. Rare Disease Genetics, Functional Genomics, and Lysosome Biology
Dr. Gomez-Ospina also studies the molecular basis of rare and undiagnosed genetic disorders. Through clinical genetics, international collaborations, and the NIH Undiagnosed Diseases Network, her work contributes to novel disease-gene discovery, functional validation of candidate variants, and definition of genotype–phenotype relationships. Her laboratory also investigates lysosomal biology and develops systems-level approaches, including the Lysosome Disease Atlas, to connect lysosome-associated genes with cellular function and human phenotypes. These efforts aim to improve diagnosis while identifying new disease mechanisms and therapeutic opportunities.
For more information go to our website:
https://www.gomezospina.com/
